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ABSTRACT
The liver  cells of intact  male rats given  ethyl-a-p-chlorophenoxyisobutyrate  (CPIB) charac-
teristically  show  a  marked  increase  in  microbodies  and in  catalase  activity,  while  those  of
intact female  rats do not. In castrated  males given estradiol benzoate and CPIB the increase
in  catalase  activity  and  microbody  proliferation  is  abolished,  while  in castrated  females
given  testosterone  propionate  and  CPIB the  livers  show  a marked  increase  in  microbodies
and  in catalase  activity.  No  sex difference  in microbody  and  catalase  response  is  apparent
in  fetal  and  neonatal  rats.  Both  sexes  show a sharp  rise  in  catalase  activity on the  day of
birth, with a rapid decline at 5 days after birth. Thyroidectomy abolishes the hypolipidemic
effect  of CPIB in rats, but microbody proliferation  and increase  in catalase  activity persists
in  thyroidectomized  male rats, indicating that microbody proliferation  can be independent
of  hypolipidemia.  Adrenalectomy  does  not  alter  appreciably  the  microbody-catalase
response  to  CPIB. These experiments demonstrate  that (1) in  adult rats, hepatic microbody
proliferation  is  dependent  to  a  significant  degree  upon  male  sex  hormone  but  is  largely
independent  of thyroid  or adrenal  gland  hormones;  (2)  hepatic microbody  proliferation  is
independent  of the hypolipidemic  effect of CPIB;  (3) displacement of thyroxine from serum
protein  may not  be sufficient cause  for stimulation  of microbody  formation.
INTRODUCTION
Previous  studies  (1,  2)  demonstrated  a significant
increase  in  number  of microbodies  (peroxisomes)
and  concomitant  rise  in  catalase  activity  in  male
rat  liver  following  administration  of  ethyl-a-p-
chlorophenoxyisobutyrate  (Clofibrate,  CPIB),  a
hypolipidemic  drug  which  lowers  serum  choles-
terol  and  triglycerides  in  man  (3)  and  in experi-
mental  animals  (4,  5).  Microbodies  are  a  class  of
cell  organelles  in  liver  and  kidney  of  several
species  and  in  the  protozoan  T.  pyriformis that
have been characterized  biochemically by de Duve
and  coworkers  (6)  who  showed  that  they  possess
enzymes  necessary  for production  and destruction
of  hydrogen  peroxide.  Leighton  et  al.  recently
reported  methods  for  mass  isolation  of  these
structures,  in  fractions  of  improved  purity,  from
livers  of rats  injected with  Triton  WR-1339  (7).
A  previous  study from  our laboratory  (2)  dem-
onstrated  that,  in  female  rats  given  doses  of
CPIB identical  to those  given to  male rats for the
same  duration,  there  was no conspicuous  increase
either in microbody number or in catalase  activity.
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Distribution  of  Rats  for  Experiments  Relating
Microbody Proliferation to  Gonadal, Adrenal,
and Thyroid Hormones
No.  of
Group  animals
Males
I.  Intact control  4
2.  Intact +  CPIB  5
3.  Castrated control  5
4.  Castrated  +  CPIB  9
5.  Castrated  +  CPIB +  estradiol  9
benzoate  (0.2  mg/day; sub-
cutaneous)
6.  Adrenalectomy  4
7.  Adrenalectomy  +  CPIB  9
8.  Thyroidectomy  11
9.  Thyroidectomy  +  CPIB  6
Females
10.  Intact  control  4
11.  Intact  +  CPIB  5
12.  Castrated control  5
13.  Castrated  +  CPIB  9
14.  Castrated  +  CPIB  +  testosterone  9
propionate  (75  g/day;  sub-
cutaneous)
15.  Adrenalectomy  4
16.  Adrenalectomy  +  CPIB  4
The primary  purpose of the experiments described
here  was  to  assess  the  relationship  of  the  CPIB-
induced  microbody  and  catalase  response  to  the
hormonal  status  of rats,  especially  with  reference
to  sex  hormones.  In  addition,  the  effect  of  thy-
roidectomy  on  hepatic  microbody  proliferation
was  investigated  since  previous  reports  (8-10)
suggested  that one  of the mechanisms  of action  of
CPIB  was  to  displace  thyroxine  from  serum  pro-
tein,  with consequent  increase  in concentration  of
thyroxine  in  liver  cells.  Since  thyroidectomy
abolishes  the  hypolipidemic  effect  of  CPIB  (8,
11),  it  was  apparent  that  examination  of  livers
from  thyroidectomized  rats  offered  one  means  of
clarifying  the  specificity  of  hypolipidemia  as  a
stimulus  for  microbody  proliferation  (1,  2,  12).
For enlarging  the basis for comparison,  livers  from
fetal,  newborn,  and  adrenalectomized  rats as well
as  from  rats  given  other  agents  that  displace
thyroxine  from  serum  protein  were  included  in
these  experiments.
MATERIALS  AND  METHODS
For experiments  designed  to study the relationship of
micrDbody  proliferation  to  the  effects  of  thyroid,
adrenal,  and  gnadal  hormones,  rats  of  both  sexes
were  distributed  a  indicated  in  Table  I.  Gonadec-
tomized  and  thyroidectomized  Sprague-Dawley  rats
were  obtained  from  Hormone  Assay  Laboratories,
Chicago,  Ill.  Bilateral  adrenalectomy  was  performed
on male  F-344 rats under  Metofane  (methoxyflurane)
anesthesia. All  animals weighed between  110 and  130
g. After removal  of gonads or thyroid glands,  animals
were  caged individually  and placed  on the basal diet
of  Purina  Chow  and  water  ad  lib  for  2  wk  before
addition  of CPIB  to the regimen.  Adrenalectomized
animals  were  treated  similarly,  but  were  given  1%
NaCI  in  their  drinking  water.  All  animals  were
weighed  weekly  and  killed  after  4  wk  on  CPIB,  at
which  time  the  liver  was  removed,  weighed,  and
separated  into  samples  for  morphological  and  bio-
chemical  studies.  In  groups  5  and  14,  estradiol
benzoate  and  testosterone  propionate,  respectively,
were  given  according  to  the  schedule  indicated  in
Table  I.
For  studying  the  effects  of other  agents  that  de-
crease  binding  of thyroxine  to  serum proteins,  eight
male  Sprague-Dawley  rats  (two rats  per group)  were
given  2,4-dichlorophenoxyacetic  acid  (0.125%  in
diet),  trypan blue  (25 mg/kg, subcutaneously),  novo-
biocin  (300  mg/kg,  i.p.) and acetylsalicylic  acid  (1%
in  diet)  for  4  wk,  at  which  time  the  animals  were
killed,  and  livers  were  removed  and  weighed,  and
samples  were  processed  for  light  and  electron  mi-
croscopy.
For  a  comparison  of  sex difference  in  microbody
response  to  CPIB  between  adult  rats  and  fetal  and
newborn  animals,  20 sperm-positive  female Sprague-
Dawley  rats  were  given  the  basal  diet  containing
0.25%  CPIB.  For  biochemical  and  morphological
examination,  five  pregnant  rats were  sacrificed  at 20
days of gestation  and the livers  of litters were pooled
according  to sex.  Livers  of newborn  and  5-day-old
rats were similarly  pooled.
Microscopy
From  all  groups, samples  of liver  were  fixed for  1
hr  at  0°C  in  2%  osmium  tetroxide  buffered  with
s-collidine  or  in  collidine-buffered  glutaraldehyde.
The  blocks  were  dehydrated  in  a  graded  series  of
alcohols  and  embedded  in  Epon  812.  Ultrathin
sections  were  cut  with  glass  knives  on  an  LKB
ultramicrotome  and  stained  with  lead.  Sections were
studied  in  an  RCA  3G  electron  microscope  with
100-kv  accelerating  voltage  and  a  25-u  objective
aperture.
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For  catalase  determinations,  1 g  of liver  in  4  ml
of M/150 phosphate buffer was homogenized at 1-4°C
with  strokes  in  a  Potter-Elvehjem  homogenizer  at
400  rpm.  Catalase  activity  was  measured  by  the
method  of Luck  (13)  after  24  hr  of extraction.  For
comparing  the  adequacy  and  reproducibility  of this
method  to  those of  alternative  methods  suggested  in
the literature,  catalase  activity  in the livers of control
male  rats  was  assayed  by  varying certain  procedures
and comparing the  results to those  obtained with the
standard  assay.  It  was  found  that  substituting  300
strokes  in  homogenizing  for  the  usual  20  strokes
resulted  in only  a slightly  higher  reading  of catalase
activity. Addition  of 1% Triton  X-100 to 1 g of liver
before  20-stroke  homogenization  gave results  similar
to  those  obtained  with  the  standard  method,  even
when assay was done immediately without  extraction
for 24 hr.
Total  proteins  were  determined  by  the  Lowry
method  (14).  All  determinations  were  done  in
duplicate.
RESULTS
Gonadal Hormones
By  4  wk,  the  livers  of  intact  male  rats  given
CPIB  showed  the  characteristic  marked  increase
in  catalase  activity  compared  to  that  of  intact
controls  (p  >  0.001)  (Fig.  1),  and  there  was  a
simultaneous  increase  in  the  number  of  micro-
bodies  (Fig.  2).  Castration  alone  had  no  appre-
ciable  effect  on the number  of microbodies  or on
estimated  catalase  activity,  and  castrated  males
given CPIB showed  no significant increase  in cata-
lase activity as compared  with the  catalase  activity
of castrated  or  intact  controls.  Estradiol  benzoate
given  to  castrated  males  receiving  CPIB  (Fig.  1)
was  associated  with  a significantly  lower catalase
activity  than  that  in  all  other  castrated  and/or
intact males.  The effect  of castration and  addition
of female  sex  hormones  to males  is most apparent
by  comparison,  in  Fig.  ,  of  catalase  activity  in
intact  rats  given  CPIB  to  castrated  rats  given
estradiol  benzoate  in  addition  to  CPIB  (p  >
0.001).  Simultaneously,  the  number  of  micro-
bodies  in liver  cells of castrated  males  given CPIB
and estradiol  benzoate did  not increase  (Fig.  3).
Conversely,  intact  female  rats  given  CPIB
typically  showed  only a  slight increase  in  catalase
activity  over  that  of  intact  controls  (p  >  0.4)
(Fig.  4)  and,  by  electron  microscopy,  their  liver
cells  had  no  appreciable  increase  in  number  of
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FIGURE  1  Effects of CPIB on liver catalase  activity in
intact male rats and in castrated  male  rats given estra-
diol benzoate.
microbodies  (Fig.  5).  Daily  injections  of  tes-
tosterone propionate  to castrated  females receiving
CPIB,  however,  were  associated  with  marked
increase  in  catalase  activity  over that  of castrated
controls  with or without  CPIB  (p  >  0.001)  (Fig.
4),  and,  simultaneously,  there  was  a  marked
increase  in  the  number  of  hepatic  microbodies
(Fig. 6).
Thyroidectomy  alone did not affect  appreciably
the  catalase  activity  of male  rats  consuming  only
Purina  Chow  (p  <  0.2)  (Fig.  7).  Similarly,  thy-
roidectomy  inhibited  only slightly  the typical ele-
vation  of hepatic  catalase  activity  in  response  to
CPIB  (p  >  0.01),  and liver  cells  of these  animals
had  the characteristic  increase  in  the  number  of
microbodies  (Fig.  8).  Adrenalectomy  in  male
rats  (Fig.  9)  did  not  inhibit  the  effect  of  CPIB
on  catalase  activity  and  microbody  proliferation
(p  >  0.005).  In  adrenalectomized  females,  there
was  no  significant  difference  in  catalase  activity
between  those  given only  Purina  Chow and those
given  Purina  Chow  plus  CPIB.  In  both  groups,
the  catalase  activity  was  equal  to  that  in  intact
females given  CPIB.
In  fetal  rats  (20th  day  of  gestation)  whose
mothers were not  given CPIB, the activity  of liver
catalase  was  essentially  similar  in both  sexes  (Fig.
10).  By  5  days  after  birth,  catalase  activity  in-
creased  to  the  same  extent  in  both  sexes  and de-
creased  to  a slight but parallel  degree  5 days  after
birth.  In  the  livers  of  fetuses  whose  mothers  re-
ceived  CPIB for the first  20  days  of gestation,  the
catalase  activity  was  elevated  in  both  sexes  over
736  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  40,  1969Figure  2  Intact male rat; CPIB, 4 wk. Liver cells show a marked increase  in the number  of microbodies
(mb).  Many microbodies  lack  nucleoids.  mt,  mitochondria.  X  9600.
737Figure  3  Castrated  male rat;  CPIB +  estradiol  benzoate,  4  wk.  There  is  no increase  in  the number  of
microbodies  (mb).  X  9600.
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FIGURE 4  Effect of CPIB on catalase activity in intact
female  rats and  in  castrated  female  rats  given  testos-
terone  propionate.
control values  at  all  three intervals  examined  but
no  significant  sex  difference  was  apparent.  Com-
pared  to fetuses from  mothers that did not  receive
CPIB,  fetuses  whose  mothers  received  CPIB
showed  an  increase  in the  number  and  diameter
of  hepatic  microbodies  in  both  sexes.  A  marked
and  approximately  equal increase in  hepatic cata-
lase  activity occurred  in  both  sexes on  the  day  of
birth,  but  this  activity  decreased  by  5  days  after
birth  (Fig.  10).
The effects  of other agents which  decrease  bind-
ing  of  thyroxin  to  serum  protein  (trypan  blue,
novobiocin,  2,4-dichlorophenoxyacetic  acid,  ace-
tylsalicylic  acid)  were  not  consistent with  respect
to  microbody  proliferation,  catalase  activity,  and
hypolipidemia.  No uniform  and consistent  change
in  these  three  parameters  occurred  with  the
agents  examined.'
DISCUSSION
The  difficulties  and  sources  of error  in  quantita-
tive comparisons  from electron  micrographs  alone
have  been  described  (15,  16),  and  de  Duve  and
coworkers  have  recently  discussed  discrepancies
between  numerical  assessment  and  protein  con-
tent  of microbodies  (peroxisomes)  (7).  Neverthe-
less,  the  uniform  method  for  assay  of  catalase
activity  used in these  experiments  indicates repro-
ducible  biochemical  changes  in  catalase  after
gonadectomy  and  sex  hormone  supplementation.
Moreover,  the  biochemical  determinations  corre-
Azarnoff, D.  and Svoboda,  D.  Unpublished  data.
late  very  well  with  the  ultrastructural  observa-
tions.
Gonadectomy
It is apparent  that, in rats, microbody prolifera-
tion following  CPIB is sensitive  to  sex  hormones.
Whether  this  sensitivity  is  inherent  in  the  micro-
body  as  such  or  is related  to  a  different  micro-
environment within  the  liver  cell owing  to  differ-
ences in  drug metabolism in  the  two  sexes cannot
be  stated with  certainty from these  experiments.
Sex  differences  in  the  response  of rodent  liver
to  drugs  has  been  demonstrated  in  a number  of
instances  (17).  For example,  the  microsomes  from
livers  of  male  rats were  more  active  than  those
from  livers  of  female  rats  in  n-demethylation  of
morphine  (18)  and in the oxidation  of hexobarbi-
tal (19).  The latter effect is obviated in females  by
the  administration  of testosterone  (19),  and  star-
vation  or  adrenalectomy  may  diminish  or abolish
the  sex  difference  in  metabloism  of drugs  by  rat
liver  microsomes  (20,  21).  In  female  rats,  the
stimulation  of  microsomal  drug  metabolism  is
more  closely  paralleled  by  anabolic  than  by
androgenic  effects  of testosterone  (22).
Gonadectomy  has little effect  on  the lowering of
total lipids and cholesterol  by CPIB  (23,  24).  The
contrast between the dependence  of CPIB-induced
microbody proliferation  on gonadal  hormones and
the  independence  from  gonadal  hormones  of
hypolipidemia  following  CPIB  suggest  that  the
two  responses  need  not  be  related,  and  experi-
ments  in  thyroidectomized  animals  (discussed
below)  support  this  interpretation.
Sex  difference  in  catalase  activity  has  been
reported  but refers  largely  to  the extraparticulate
catalase  which  comprises only  a small  proportion
of  the  total  (25).  Adams  demonstrated  that  in
mice  castration  or  castration  plus  adrenalectomy
resulted,  in  48  hr, in  a  significant  fall  in  catalase
activity,  although  in  females  ovariectomy  alone
caused  no  change  (26).  Adams  also  showed  that
in  males  depression  of catalase  activity  by  castra-
tion  is reversed  or  restored  by  injection  of  tes-
tosterone,  while  in  females  testosterone  elevates
their  normal  lower  level  of  catalase  activity  to
that  of  the  male.  The  microbody-catalase  re-
sponses  in  rats  in  the  present  experiments  are,
therefore,  in  general  agreement  with  earlier
reports.
Most  sex  differences  in  drug  metabolism  are
seen  only  in  the  rat  (17,  19);  sex  difference  in
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_Figure 5  Intact female  rat;  CPIB,  4  wk.  There  is no  increase  in  number  of microbodies  in liver  cells.
Instead,  the cells  resemble those  of castrated male rats given estradiol benzoate  with  CPIB  (compare to
Fig. 3)  or those of intact controls of either sex not given  CPIB.  mt,  mitochondria.  ly,  lysosomes.  X  9600.
740  THE  JOURNAL  OF  CELL  BIOLOGY  VOLUME  40,  1969Figure 6  Castrated female  rat;  CPIB  +  testosterone  propionate,  4  wk.  Liver  cells contain  numerous
microbodies and resemble the cells  of intact male rats given CPIB (cf.  Fig. 2). In addition to those with a
typically  dense  matrix  (mbl),  several  microbodies  have a  pale  matrix  with decreased  electron  opacity
(mb2). Although the reason for differences  in electron opacity  of the matrix is unknown,  similar differences
are present  in hepatic microbodies  of intact male rats given CPIB  (1).  mt, mitochondria.  X 9600.
SVOBODA,  AZARNOFF,  AND  REDDY  Microbodies in Altered Cells. II  741100
z  90
- 80
0
a_ 70
E  60
- 50
Z  40
W  30
-J  20
I--
<  I0
0
FIGURE  7  Effect of  CPIB  on liver catalase  activity  in
male  rats  after  thyroidectomny.
hypolipidemic response to CPIB in man, in clinical
trials  of the drug,  has  not  been  noted  to  any sig-
nificant  degree.  Hess  and  coworkers  observed,
however,  that female  rats responded  more  slowly
than  males  to  CPIB-induced  elevation  of  mito-
chondrial  glycerol-l-phosphate  dehydrogenase  ac-
tivity  (27).
The  presence  of  androgens  per  se,  or  their
anabolic  effects,  may  be  important  factors  in
determining  sex  variation  in  activity  of  micro-
somal  drug-metabolizing  enzymes.  The  extrapo-
lation  of  observations  of  microsomal  enzyme  in-
duction  to  microbody  enzyme  induction  can  only
be  tentative  at  the  present  time,  but  it  appears
that the simultaneous  increase  in microbodies  and
in  the activity  of their main  constituent,  catalase,
represents a  new form of enzyme  induction  analo-
gous  to  the  increase  in  smooth  endoplasmic
reticulum  and  concomitant  increase  in  micro-
somal  enzyme  activity  following  administration
of more familiar enzyme inducers such as  dichloro-
diphenyldichloroethane  (DDD)  (28)  or  pheno-
barbital  (29).
It  may  be  of  interest  to  note  that,  in  CPIB-
treated  male  rats,  while  catalase  activity  is  in-
creased,  there  is  80%  reduction  in  activity  of
D-amino  and L-a-hydroxy  acid oxidases in hepatic
microbodies  (30).  This  observation  indicates  that
the main  enzymes  of  these  organelles  do  not  re-
spond  in  parallel  fashion  to  the  effects  of CPIB.
It  appears,  therefore,  that,  following  administra-
tion  of  CPIB,  there  may  be  either  considerable
dissociation  among  the  enzyme  constituents  of
individual  microbodies  or  that  a  heterogeneous
population  of these  organelles  arises.
Fetal Rats
Several  investigators  (31-33),  studying  fetal  rat
and  mouse  liver,  have  reported  that  the  earliest
appearance  of  microbodies  occurs  between  the
15th  and  18th  day  of  gestation  and  that  their
number  increases  up  to the day  of birth.  Tsukada
and coworkers  (34) described  in detail the number
and  development  of  microbodies  and  enclosed
nucleoids  during  postnatal  development  and
suggested,  as  did  Essner  (31),  that  microbodies
originated  from  granular  endoplasmic  reticulum.
Similarly,  Higashi  and  Peters  (35)  showed  that,
in  microsomes,  catalase  was  first  associated  with
the  granular fraction.
From  the  present  experiments,  it  is  clear  that
the  sex difference  in microbody  response  to  CPIB
observed  in  adult  rats  is not  manifest in  fetal  and
early  neonatal  rat  liver.  Previous  studies  have
shown that,  before  puberty,  there  is  no sex  differ-
ence  in  rats  with  respect  to  their  response  to
hexobarbital  (19).  Related  studies in mice, guinea
pigs  (36),  and  rabbits  (37)  have  shown  that  the
fetal  livers  of  these  species  lack  several  of  the
drug-metabolizing,  microsomal  enzymes  that  are
present  in  the  livers  of  adults  of  the  respective
species.  Changes  in  microbodies  and  catalase
activity,  after  the  5th  postnatal  day,  were  not
studied  in  the  present  experiments,  but Tsukada
et  al.  (34)  described  continuous  increase  in  cata-
lase  activity  of  livers  from  male  rats  up  to  60
days.  In  considering  the  microbody  and  catalase
response  of  rat  fetal  liver  cells  to  CPIB,  it  is  of
interest  to  compare  the  present  findings  to  re-
lated  observations  in  other  conditions  in  which
liver  cells  divide  rapidly.  For  example,  Dalton
suggested  that  the  number  of  microbodies  in
liver  tumors  was  inversely  proportional  to  the
growth  rate  of the  tumor  cells  (38).  But  growth
rate  or  mitotic rate  may  not be  significant  factors
in  determining  response  of microbodies to  CPIB,
since cells  in fetal or regenerating  (2)  liver  appear
to  be  comparable  to  cells  in normal  adult  liver  in
their  capacity  to  produce  microbodies.  On  the
other  hand,  from  additional  experiments,  it  was
evident  that cells  of chemically  induced,  but well
differentiated  and  comparatively  slowly  growing
primary  hepatomas  do  not  produce  an  increased
number of microbodies  in response  to CPIB.2
2  Svoboda,  D.,  and  D.  Azarnoff.  Unpublished  ob-
servations.
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'AAFigure 8  Male  rat;  thyroidectomy;  CPIB,  4  wk.  Liver  cells  show  the  typical  increase  in  number  of
microbodies  (mb).  mt,  mitochondria.  X  8,800.
743Thyroidectomy
It  has  been  shown  that  endogenous  thyroxine
is  necessary  for  the  effect  of  CPIB  in  decreasing
serum  lipids  (8,  11,  24).  In  the  present  experi-
ments,  the  observation  that,  despite  thyroidec-
tomy,  hepatic  microbody  proliferation  occurs
with  CPIB  feeding  indicates  that  the  hypolipi-
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FIGURE  9  Effect  of  CPIB  on liver catalase  activity in
male rats after adrenalectomy.
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demic effect of CPIB  is separable  from the micro-
body-stimulating  effect;  and,  conversely,  that
microbody  proliferation  may  be  independent  of
hypolipidemia per se.
To explain  the mode  of action of CPIB on lipid
metabolism,  it has been suggested  that the chloro-
phenoxyisobutyrate  anion  displaces  serum  albu-
min-bound  acidic  substrates,  cenzymes,  and
hormones,  notably thyroxine  (9),  with consequent
uptake  of thyroxine  in the  liver  (10).  It  has been
proposed  that,  because  of  the  displacement  of
thyroxine  by  CPIB into the liver,  the  net result is
the  production  of  a  hyperthyroid  effect  in  the
liver  with  relative  hypothyroid  levels  in  the  rest
of the body  (39).  However,  ultrastructural changes
in mitochondria  from liver  cells  (40)  and skeletal
muscle  cells  (41)  from  rats  given  thyroxine  were
not  apparent  in  any  CPIB-treated  animals.
Experiments  with  other  agents  that  displace
thyroxine  from  plasma  protein  tend  to  substan-
tiate  the  contention  that  thyroxine  displacement
from  plasma  proteins  by  CPIB  need  not  be  the
sine qua  non  of CPIB activity  as  far  as  microbody
proliferation  is  concerned.  For example,  novobio-
cin  and  trypan  blue,  substances  that  displace
thyroxine  from  its  plasma  protein  binding  sites
(42),  have  no  effect  on  microbody  proliferation,
.0.....o  FEMALE  CONTROLS
0---  a1""'/  6-iA  MALE  CONTROLS
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FIGURE  10  Effect  of  CPIB, on  liver
catalase  activity in fetal  and  neonatal
rats of both sexes.
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Iocatalase  activity,  or hypolipidemia.3 2,4-dichloro-
phenoxyacetic  acid,  structurally  similar  to  CPIB
and  capable  of  lowering  serum  cholesterol  (43),
does  not  affect  microbody  number  or  catalase
activity.  Perhaps  acetylsalicylic  acid  more  closely
approximates  CPIB  in  its  effects  on  all  three
parameters,  although  its  effect  on  the number  of
microbodies  (44)  and  catalase  acitivty  is  not  so
pronounced  as that of CPIB.
Chang  and  coworkers  (45)  observed  species
differences  in  the  degree  of  displacement  by
CPIB  of  thyroxine  from  the  various  fractions  of
plasma  protein  and  pointed  out that,  in the  rat,
CPIB  depressed  only  the relatively  less  important
albumin-bound  thyroxine rather than that portion
of thyroxine  bound  to  alpha-globulin.  Since  the
importance  of  albumin  binding  of  thyroxine  in
the  rat is  still  open  to dispute,  no  conclusion  can
be drawn  regarding  the relationship  of thyroxine
displacement  to  microbody  proliferation  in  this
species.  In any event,  it appears that the  effect  of
CPIB  on  free  thyroxine  concentration  in  circu-
lating blood is much less in  the rat than in man or
the  dog  (45),  and  this observation,  coupled  with
the absence  of changes  in  mitochondrial  structure
that  typically  occur  owing  to  local  elevation  of
thyroxine  concentration  in  liver  cells,  suggests
that  thyroxine  displacement  is  not  a  sufficient
mechanism  for  microbody  proliferation.  The
possibility  exists,  however,  that  displacement  of
other  anionic  compounds,  such  as  androgenic
sulfates,  from  their  plasma  protein-binding  sites
may  account for the  increase in  number of micro-
bodies.
Of special  relevance  to  the present  studies  are
the  experiments  of  Blum  and  Wexler  (46)  who
showed  that  even  in  the  unicellular  organism,
Tetrahymena pyriformis, a  ciliated protozoan  known
to  contain  peroxisomes  (6),  CPIB  causes  a  20%
increase  in catalase activity.
Adrenalectomy
Previous  studies  (23,  47)  have  shown  that the
effectiveness  of CPIB in  rats varied  with  seasonal
fluctuations  in  thyroid  and  adrenocortical  activ-
ity,  and  that  the  maximal  effect  of CPIB  on rat
serum  cholesterol  corresponded  to  the  period  of
maximal  adrenocortical  and  thyroid  function.
Best  and  Duncan  (8)  also  found  that  adrenalec-
tomy  in  rats  abolished  the  effects  of  CPIB  on
lipids,  and  Thorp  and  Barrett  (24)  stated  that
adrenal  17-ketosteroids  were  necessary  for lower-
ing of lipids by CPIB.  In the present experiments,
adrenalectomy  in  male  rats  caused  a  slight  de-
crease  in  catalase  activity,  as  has  been  noted
previously  in  rats (48)  and mice  (49,  50),  but did
not  inhibit  the  CPIB-induced  elevation  of cata-
lase  activity  (Fig.  9)  or  proliferation  of  micro-
bodies.  It  is  clear,  therefore,  that  neither  thyroid
or  adrenal  hormones  are  necessary  for  CPIB-
induced microbody proliferation.
These  studies  were  supported  in  part  by  United
States  Public  Health  Service  Grants  CA-5680,  CA-
8055, GM-15956,  and  HE-7601.
CPIB  was supplied  by Dr. Jerome  Noble,  Ayerst
Laboratories. Technical  assistance was given by Mrs.
Lynne Schmutz,  Mrs. Faye  Brady,  and Miss Dianne
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